FDA Warns API Manufacturers in India, Michigan
The FDA issued warnings to Indian API manufacturer Vikshara Trading and Investments over serious violations, including hindering the agency’s investigation, and to Huron Pharmaceuticals, citing quality documentation issues.
Source: Drug Industry Daily